Melanin-covered nanoparticles for protection of bone marrow during radiation therapy of cancer

Clicks: 233
ID: 273062
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
MNs or similar structures provide a novel approach to protection of bone marrow from ionizing radiation based on prevention of free radical formation by melanin.
Reference Key
ad2010internationalmelanin-covered Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Schweitzer AD;Revskaya E;Chu P;Pazo V;Friedman M;Nosanchuk JD;Cahill S;Frases S;Casadevall A;Dadachova E;;
Journal international journal of radiation oncology, biology, physics
Year 2010
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20421152&dopt=Abstract
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't non-p.h.s. N.I.H. Extramural microscopy electron nude transmission magnetic resonance spectroscopy pmid:20421152 pmc3001108 doi:10.1016/j.ijrobp.2010.02.020 andrew d schweitzer ekaterina revskaya ekaterina dadachova bone marrow / metabolism* bone marrow / radiation effects drug carriers / chemical synthesis drug carriers / pharmacokinetics melanins / administration & dosage melanins / chemical synthesis melanins / pharmacokinetics* melanoma / metabolism melanoma / radiotherapy nanoparticles* / administration & dosage radiation injuries experimental / prevention & control* radiation-protective agents / administration & dosage radiation-protective agents / chemical synthesis radiation-protective agents / pharmacokinetics* radioimmunotherapy / adverse effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.